Literature DB >> 19735872

Estimation of errors associated with use of linear-quadratic formalism for evaluation of biologic equivalence between single and hypofractionated radiation doses: an in vitro study.

Hiromitsu Iwata1, Yuta Shibamoto, Rumi Murata, Natsuo Tomita, Shiho Ayakawa, Hiroyuki Ogino, Masato Ito.   

Abstract

PURPOSE: To investigate the reliability of the linear-quadratic (LQ) formalism and the magnitude of errors associated with its use in assessing biologic equivalence between single, high radiation doses and hypofractionated radiation doses. METHODS AND MATERIALS: V79 and EMT6 single cells received single doses of 2-12 Gy or two or three fractions of 4 or 5 Gy, each at 4-h intervals. Single and fractionated doses to actually reduce the cell survival to the same level were determined by a colony assay. The alpha/beta ratio was obtained from the cell survival curves. Using the alpha/beta ratio and the LQ formalism, equivalent single doses for the hypofractionated doses were calculated. They were then compared with the actually determined equivalent single doses for the hypofractionated doses. The V79 spheroids received single doses of 5-26 Gy or two to five fractions of 5-12 Gy at 2 or 4-h interval, and then were assayed for cell survival. Next, equivalent single doses for the hypofractionated doses were determined, as were done for the single cells.
RESULTS: The alpha/beta ratio was 5.1 Gy for the V79 single cells and 0.36 Gy for EMT6. In V79, the equivalent single doses for the hypofractionated doses calculated using the LQ formalism were 12-19% lower than the actually measured biologically equivalent single doses. In the EMT6 cells, this trend was also seen, but the differences were not significant. In the V79 spheroids, the calculated doses were 18-30% lower than the measured doses.
CONCLUSION: Conversion of hypofractionated radiation doses to single doses using the LQ formalism could underestimate the effect of hypofractionated radiation by < or =30%.

Entities:  

Mesh:

Year:  2009        PMID: 19735872     DOI: 10.1016/j.ijrobp.2008.12.093

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  15 in total

1.  Hypofractionated stereotactic radiotherapy with CyberKnife for nonfunctioning pituitary adenoma: high local control with low toxicity.

Authors:  Hiromitsu Iwata; Kengo Sato; Koshi Tatewaki; Naoki Yokota; Mitsuhiro Inoue; Yoshimi Baba; Yuta Shibamoto
Journal:  Neuro Oncol       Date:  2011-06-10       Impact factor: 12.300

2.  A new formalism for modelling parameters α and β of the linear-quadratic model of cell survival for hadron therapy.

Authors:  Oleg N Vassiliev; David R Grosshans; Radhe Mohan
Journal:  Phys Med Biol       Date:  2017-10-03       Impact factor: 3.609

3.  Clinical outcomes of stereotactic body radiotherapy for stage I non-small cell lung cancer using different doses depending on tumor size.

Authors:  Fumiya Baba; Yuta Shibamoto; Hiroyuki Ogino; Rumi Murata; Chikao Sugie; Hiromitsu Iwata; Shinya Otsuka; Katsura Kosaki; Aiko Nagai; Taro Murai; Akifumi Miyakawa
Journal:  Radiat Oncol       Date:  2010-09-17       Impact factor: 3.481

Review 4.  What would be the most appropriate α/β ratio in the setting of stereotactic body radiation therapy for early stage non-small cell lung cancer.

Authors:  Alexander Chi; Sijin Wen; Zhongxing Liao; Jack Fowler; Jiahong Xu; Nam P Nguyen; James S Welsh; Ritsuko Komaki
Journal:  Biomed Res Int       Date:  2013-11-20       Impact factor: 3.411

5.  Treatment of single or multiple brain metastases by hypofractionated stereotactic radiotherapy using helical tomotherapy.

Authors:  Aiko Nagai; Yuta Shibamoto; Masanori Yoshida; Koichi Wakamatsu; Yuzo Kikuchi
Journal:  Int J Mol Sci       Date:  2014-04-22       Impact factor: 5.923

6.  Applicability of the linear-quadratic model to single and fractionated radiotherapy schedules: an experimental study.

Authors:  Akifumi Miyakawa; Yuta Shibamoto; Shinya Otsuka; Hiromitsu Iwata
Journal:  J Radiat Res       Date:  2013-12-17       Impact factor: 2.724

7.  Compatibility of the repairable-conditionally repairable, multi-target and linear-quadratic models in converting hypofractionated radiation doses to single doses.

Authors:  Hiromitsu Iwata; Naruhiro Matsufuji; Toshiyuki Toshito; Takashi Akagi; Shinya Otsuka; Yuta Shibamoto
Journal:  J Radiat Res       Date:  2012-10-16       Impact factor: 2.724

Review 8.  Radiobiology of radiosurgery for the central nervous system.

Authors:  Antonio Santacroce; Marcel A Kamp; Wilfried Budach; Daniel Hänggi
Journal:  Biomed Res Int       Date:  2013-12-29       Impact factor: 3.411

9.  Safety and efficacy of intensity-modulated stereotactic body radiotherapy using helical tomotherapy for lung cancer and lung metastasis.

Authors:  Aiko Nagai; Yuta Shibamoto; Masanori Yoshida; Koji Inoda; Yuzo Kikuchi
Journal:  Biomed Res Int       Date:  2014-06-04       Impact factor: 3.411

Review 10.  Radiation oncology in vitro: trends to improve radiotherapy through molecular targets.

Authors:  Natália Feofanova; Jony Marques Geraldo; Lídia Maria de Andrade
Journal:  Biomed Res Int       Date:  2014-09-15       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.